MedPath

The Efficacy and Safety of Huoxuo Qianyang Qutan Dection in the Treatment of Hypertension: a Randomized, Double-blind, Placebo-controlled Trial

Phase 1
Recruiting
Conditions
hypertension
Registration Number
ITMCTR2000003526
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Outpatient or hospitalized patients with primary hypertension of grade 1 and 2; aged from 18 to 75 years, regardless of gender;
(2) Meet the diagnostic criteria of Yang hyperactivity-blood stasis-phlegm turbidity in traditional Chinese medicine;
(3) Under the circumstance of understanding the content of this research, can answer the questions clearly, participate voluntarily and sign the informed consent form.

Exclusion Criteria

(1) Women who are pregnant, or are about to become pregnant in the near future, or are breast-feeding;
(2) Severe damage to heart, liver, kidney function and other serious or even life-threatening diseases;
(3) Research subjects cannot cooperate due to alcoholism, intellectual disability, etc.;
(4) Other situations deemed inappropriate by other researchers;
(5) Those who are participating in other clinical research;
(6) Those who are allergic to multiple drugs.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.